Choksi Imaging Ltd Directors Report.


The Members,

Choksi Imaging Limited

Your Directors have pleasure in presenting the 28th Annual Report of the Company together with the Audited Statements of Accounts for the year ended March 31, 2020.


The Companys performance during the year ended March 31, 2020 as compared to the previous financial year, is summarized below:

Particulars 2019-2020 2018-2019
Total Revenue 1706.11 1896.95
Profit/(Loss) Before Depreciation, Amortisation, Exceptional & Extraordinary
Items and Tax (35.66) 121.74
Less: Depreciation and Amortisation expense 17.48 21.21
Profit/(Loss) Before Exceptional & Extraordinary Items And Tax (53.14) 100.53
Net Profit/(Loss) Before Tax (NPBT) (53.14) 100.53
Less: Tax expenses 2.42 14.95
Net Profit/(Loss) After Tax (NPAT) (55.56) 85.57
Amount available for Appropriations (55.56) 85.57


The total long term borrowings of your Company as on March 31, 2020 stood at NIL, Cash and Cash Equivalent stood at Rs.811.49 lac and total investments is 686.82 Lac at the end of the year.


Your Company is engaged in the business of manufacturing & trading of X ray films and supply of other products for the Healthcare Industry. During the year under the review, your Company earned a total income of Rs.1706.11 as against Rs.1896.95 during the previous year. The Directors of the company are exploring new opportunities in health care sector.

The World Health Organization (WHO) declared COVID-19 to be a global pandemic in March 2020. Most of the countries across the world were into lockdown situation, all throughout April 2020 and May 2020, impacting business across various sectors with severe restrictions on movement of people and goods. The Company has implemented several initiatives across its manufacturing and other offices by allowing employees to work from homes, keeping social distancing at work places and proper sanitization, at regular intervals, of work places, etc. for ensuring safety of its employees and continuity of its business operations with minimal disruption. Since, the Company is operating in Healthcare Industry, there is no significant adverse impact on operation of the company due to COVID 19.


In the View of the loss for the year, your Directors have not declared any final dividend for the year 2019-2020.


The Company has not transferred any amount to General Reserves.


The paid up Equity Share Capital as at March 31, 2020 stood at Rs.390 lac. During the year under review, the Company has not issued shares with differential voting rights nor has granted any stock options or sweat equity. As on March 31, 2020, none of the Directors of the Company hold instruments convertible into equity shares of the Company.


During the year under the review, there is no change in accounting policy of the Company.


During the year under review, your Company did not have any subsidiary, associate and joint venture company.


As per Regulation 15 (2) read with Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company does not require to submit corporate governance report. A detailed report on Industry Structure and Developments, Operations, Performance, Business Outlook, Opportunities & Threats and Risks and Concerns, is presented in a separate section forming a part of the Annual Report.


Director Retiring by Rotation:

As per the provisions of Section 152 of the Companies Act, 2013, Mr. Naimish Choksi and Mr. Gaurav Choksi retires by rotation at the ensuing Annual General Meeting and being eligible, offer themself for re-appointment. Your Directors recommend their reappointment.

Appointment of Managing Director:

The Nomination & Remuneration Committee and the Board, have approved the re- appointment of Mr. Anil Choksi as Managing Director for period of 1 year w.e.f September 1, 2020, at a remuneration of Rs.6,00,000/- (Rupees Six Lac only) per annum i.e. Rs.50,000/- (Rupees Fifty Thousand only) per month. Approval of the shareholders is sought for the same in this ensuing Annual General Meeting.

Appointment of Independent Directors and declaration of independence:

During the year, The Company has not appointed any Independent Director. The Company has received declarations from all the Independent Directors of the Company confirming that they meet with the criteria of independence as prescribed under sub section (6) of Section 149 of the Companies Act, 2013.

Appointment of Key Managerial Personnel:

No Key Managerial Person has been appointed or has retired or resigned during the year.


Pursuant to the provisions of the Companies Act, 2013 and Regulation 17 of the Listing Regulation and SEBI Circular dated February 1, 2020, the committee updates the criteria of Board evaluation. The company has evaluated the performance of Board of Directors.


The Company has adopted a Remuneration Policy for the Directors, Key Managerial Personnel and other employees, pursuant to the provisions of the Act and the Listing Regulations. The policy on Nomination & Remuneration is available on website of the Company at


In terms of Section 134(5) of the Companies Act, 2013, in relation to the audited financial statements of the Company for the year ended March 31, 2020, the Board of Directors hereby confirms that:

(a) In the preparation of the annual accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures;

(b) the directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the company at the end of the financial year and of the profit and loss of the company for that period;

(c) The directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the company and for preventing and detecting fraud and other irregularities;

(d) The directors had prepared the annual accounts on a going concern basis; and

(e) The directors, in the case of a listed company, had laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively.

(f) The directors had devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems were adequate and operating effectively.


Board Meetings:

The Board of Directors of the company met 4 times on May 25, 2019, July 29, 2019, October 18, 2019 & February 1,2020.

Committees of the Board:

With a view to have a more focused attention on business and for better governance and accountability, the Board has constituted the mandatory committees viz. Audit Committee, Stakeholders Relationship Committee and Nomination and Remuneration Committee. All members of the Committees are financially literate, with Mr. Himanshu Kishnadwala is Chairman of the Audit Committee & Stakeholders Relationship Committee and Mr. Tushar Parikh is Chairman of Nomination and Remuneration committee.

The meetings of the Audit Committee were held on May 25, 2019, July 29, 2019, October 18, 2019 & February 1,2020. The gap between two Audit Committee meetings was not more than 4 months, in compliance with the requirements of the Listing Regulations.

The Meetings of Nomination and Remuneration Committee were held on May 25, 2019 & February 1, 2020. The meeting of


All contracts / arrangements / transactions entered by the Company during the financial year with related parties are given in Annexure I in form AOC-2.

Further, during the year, the Company had not entered into any contract / arrangement /transaction with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions. Prior omnibus approval of the Audit Committee is obtained for the transactions which are repetitive in nature. A statement of all Related Party Transactions is placed before the Audit Committee for its review on a quarterly basis, specifying the nature, value and terms and conditions of the transactions.

The details of the related party transactions as required under Accounting Standard - 18 are set out in Note to the financial statements forming part of this Annual Report.

The Policy on Related Party Transactions as approved by the Board has been uploaded on the website of the Company.


Your Company has not accepted any public deposits during the financial period under review.


The Company does not required to obtain Credit Rating for the year 2019-20


Statutory Auditors:

Pursuant to the provisions of Section 139 of the Companies Act, 2013 and the Companies (Audit and Auditors) Rules, 2014, M/s. KARIA & SHAH, Chartered Accountants, has been appointed by the Board of Directors as Statutory Auditors of the Company from conclusion of 25th Annual General Meeting held on September 23, 2017 till conclusion of 30th Annual General Meeting. The Company has received a confirmation from the Auditors that they are not disqualified to act as the Auditors and are eligible to hold the office as Auditors of the Company.

Secretarial Auditors:

Provisions of Section 204 read with rules made thereunder, Ms. Nikita Pedhdiya, Nikita Pedhdiya & Associates, Practicing Company Secretaries (C.P No. 14295) had been appointed to undertake Secretarial Audit of the Company for the year 2019 -2020. The report of the Secretarial Auditor is annexed herewith as Annexure II and forms part of this Report.

The said report does not contain any observation or qualification requiring explanation or comments from the Board under Section 134(3) of the Companies Act, 2013.

Internal Auditors:

Pursuant to provisions of Section 138 read with read with rules made thereunder, the Board has appointed Mr. R S Bindra, Chartered Accountants, as an Internal Auditors of the Company for the period 2019-2020 to check the internal controls and functioning of the activities and recommend ways of improvement. The Internal Audit report is placed in the Audit Committee Meeting and the Board Meeting for their consideration and direction.

The Internal Financial Controls with reference to financial statements as designed and implemented by the Company are adequate. During the year under review, no material or serious observation has been received from the Internal Auditors of the Company for inefficiency or inadequacy of such controls.


In the opinion of the directors, the notes to financial statements are self-explanatory and adequately explain the matters, which are dealt within the Auditors Report. The said report does not contain any observation or qualification requiring explanation or comments.


Provisions of Section 148 of the Companies Act, 2013 read with Notifications/Circulars issued by the Ministry of Corporate Affairs from time to time, the requirement of appointment of Cost Auditor is not applicable to your Company.


The Company has in place an adequate system of internal controls & policy on closure of Financial Statements. It has documented policies and procedures covering all financial and operating functions and processes. These have been designed to provide a reasonable assurance with regard to maintaining of proper accounting controls for ensuring reliability of financial reporting, monitoring of operations, protecting assets from unauthorized use or losses and compliance with regulations.

Adequate internal control systems commensurate with the nature of the Companys business and size and complexity of its operations has been recognized. Internal control systems ensure reliability of financial reporting, timely feedback on achievement of operational and strategic goals, compliance with applicable laws and regulations and that all assets and resources are acquired economically, used efficiently and adequately protected.


In accordance with Section 134 of Companies Act, 2013, the Company has in place the Risk Assessment and Minimization Policy to avoid events, situations or circumstances which may lead to negative consequences on the Company & businesses, and define a structured approach to manage uncertainty and to make use of these in their decision making pertaining to all business divisions and corporate functions. Key business risks and their mitigation are considered in the business plans and in periodic management reviews.

The Constitution of Risk Management Committee is not applicable to your Company. Some of the risks and threats that the company is exposed to are- Technological Obsolescence :

The company strongly believes that technological obsolescence is a practical reality. Technological obsolescence is evaluated on a continual basis. The use of technology is mainly concentrated in the area of manufacturing of Medical and Industrial X-ray films. The innovation and advancement in technology is concentrated on improving the quality of the films, increasing the output by reducing the time-lag involved and reducing the wastages.

Fluctuations In Foreign Exchange :

While our functional currency is the Indian rupee, we transact a significant portion of our business in USD and accordingly face foreign currency exposure from our purchase in other countries and from our purchases from overseas suppliers in U.S. dollars and other currencies and are exposed to substantial risk on account of adverse currency movements in global foreign exchange markets.

Legal Factors :

Legal risk is the risk in which the Company is exposed to legal action. As the Company is governed by various laws and the Company has to do its business within four walls of law, where the Company is exposed to legal risk exposure.


The Company regards its human resource as amongst its most valuable assets and proactively reviews policies and processes by creating a work environment that encourages initiative, provides challenges and opportunities and recognizes the performance and potentials of its employees.

At CIL, there is consistent emphasis on each individuals sense of responsibility, while simultaneously as part of a team. This results in our peoples ability to work in perfect harmony despite coming from different disciplines. As of March 31, 2020, the number of employees on our payroll was 44.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO (A) Conservation of energy-(i) The steps taken or impact on conservation of energy;

We had replaced Voltas Air Condition Plant which was having rotary compressors with Bluestar Scroll compressor based plant. This has resulted in 25% saving in energy consumption.

(ii) The steps taken by the company for utilising alternate sources of energy;

The Company is in process of installation of 7.5 KWp Grid Connected Rooftop Solar PV Plant at our Factory located in the State of Dadra and Nagar Haveli.

One (1) Kilo Watt system shall be generating approximately 1500 kwh per annum. The life of the project is considered for 25 years.

(iii) The capital investment on energy conservation equipments;

During the year, the Company has invested and made advance payment of 50% on aforementioned solar plant.

(B) Technology absorption-

(i) the efforts made towards technology absorption;

The interleaving operation has been partially automated.

(ii) the benefits derived like product improvement, cost reduction, product development or import substitution;

Improvement in product quality and reduction in production cost.

(iii) in case of imported technology (imported during the last three years reckoned from the beginning of the financial year) - N.A.

(iv) the expenditure incurred on Research and Development. N.A.


The fluctuations in the market were high due to depreciation of rupee against the dollar but your Company was able to manage the volatility in a prudent manner due to which losses were minimized.

Sr. No Particulars Current Year ( in lakh) Previous year ( in lakh)
1 Foreign Exchange Earnings Nil Nil
2 Foreign Exchange Outgo Nil 7.86


The information required under Section 197 of the Companies Act, 2013 read with Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 in respect of employees of the Company is provided in Annexure III forming part of this report.


The ratio of the remuneration of each Director to the median remuneration of the employees of the Company for the financial year under review has been marked as Annexure III.


The Company has adopted a Whistle Blower Policy, to provide a formal mechanism to the Directors and employees to report their concerns about unethical behaviour, actual or suspected fraud or violation of the Companys Code of Conduct or ethics policy. The Policy provides for adequate safeguards against victimization of employees who avail of the mechanism and also provides for direct access to the Chairman of the Audit Committee. It is affirmed that no personnel of the Company has been denied access to the Audit Committee.


In accordance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and rules made thereunder, the Company has framed and adopted a policy for Prevention of Sexual Harassment at Workplace.

The Company has not received any complaint of sexual harassment during the financial year 2019-20.


The Provisions of Section 135 of Companies Act, 2013 is not applicable to your Company.


Extract of the Annual Return in form MGT-9 pursuant to Section 92(3) of the Companies Act, 2013 for the financial year ended March 31, 2020 is provided in Annexure IV forming part ofthis report.


The Company has made an investment during the year of Rs.686.82 lac in various Liquid Fund. The Investment is calculated at market value as on March 31, 2020.

The Company has not given any loans or provided any security during the year.


The Jury Trial demand had been received by the Company on December 24, 2019 from Carestream Health Inc. (CHI) (creditors of the Company) filed before United States District Court Western District of New York. The Company then entered into Settlement Agreement with Carestream Health Inc. on July 9, 2020. The Company will remit settlement amount of USD $1,800,000 to CHI on account of trade payable withhold by the Company for amount of USD $2,098,845. Carestream Health India Pvt. Ltd., (Wholly owned subsidiary of CHI) will pay to the Company amount of INR2,48,04,566 against trade receivables of the Company. CHI has given corporate indemnity for 67% of all non-appealable cost in Customs case.

Except above, no other material changes and commitments which could affect the Companys financial position have occurred between the end of the financial year of the Company and date of this report.

The Company had received of order from Commissioner of Customs from the Authority for payment of Special Additional Duty along with penalty against exemption availed by the Company pursuant to Notification No. 45/2005 - Customs dated May 16,2005.


The standards of health of workers and safety measures to be taken as provided by the Factories Act, 1948 and the rules framed there under have been maintained by your Company.


Statements in this Boards Report and Management Discussion and Analysis describing the Companys objectives, expectations or predictions may be forward looking within the meaning of applicable securities, laws and regulations. Actual results may differ materially from those expressed in the statement. Important factors that could influence the Companys operations include change in government regulations, tax laws, economic & political developments within and outside the country and such other factors.


The Company has maintained operational website for the year 2019-20 i.e. www,


Your Directors wish to thank all the employees of the Company for their dedicated service during the year. They would also like to place on record their appreciation for the continued co-operation and support received by the Company during the year from bankers, financial institutions, business partners and other stakeholders.

Your Directors give their warm gratitude to the shareholders for their faith in the Company. The directors also sincerely appreciate the professionalism and dedication displayed by the employees of the Company.

On behalf of the Board of Directors

Sd/- Sd/-
Anil Choksi Gaurav Choksi
Director Director
Date: June 17, 2020
Place: Mumbai